Christian S. Schade

2021

In 2021, Christian S. Schade earned a total compensation of $3.2M as Chairman and Chief Executive Officer at Aprea Therapeutics, a 17% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$265,225
Option Awards$1,444,310
Salary$530,450
Stock Awards$993,000
Total$3,232,985

Schade received $1.4M in option awards, accounting for 45% of the total pay in 2021.

Schade also received $265.2K in non-equity incentive plan, $530.5K in salary and $993K in stock awards.

Rankings

In 2021, Christian S. Schade's compensation ranked 4,136th out of 12,415 executives tracked by ExecPay. In other words, Schade earned more than 66.7% of executives.

ClassificationRankingPercentile
All
4,136
out of 12,415
67th
Division
Manufacturing
1,704
out of 5,505
69th
Major group
Chemicals And Allied Products
704
out of 2,375
70th
Industry group
Drugs
626
out of 2,096
70th
Industry
Pharmaceutical Preparations
440
out of 1,546
72nd
Source: SEC filing on June 10, 2022.

Schade's colleagues

We found three more compensation records of executives who worked with Christian S. Schade at Aprea Therapeutics in 2021.

2021

Eyal Attar

Aprea Therapeutics

Chief Medical Officer

2021

Scott Coiante

Aprea Therapeutics

Chief Financial Officer

2021

Gregory Korbel

Aprea Therapeutics

Chief Operating Officer

News

You may also like